Costs and consequences of botulinum toxin type A use
✍ Scribed by Francis J. Ruiz; Julian F. Guest; Almut Lehmann; Alison M. Davie; Karen Güttler; Olaf Schlüter; Götz Dreiss
- Publisher
- Springer
- Year
- 2004
- Tongue
- French
- Weight
- 371 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1618-7598
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Fifteen patients with torticollis who had been treated with repeated injections of botulinum toxin type A (botox A) developed antibodies to the toxin. This resulted in loss of benefit in the 13 patients who had improved with botox A injections and failure to develop muscle atrophy after
## Abstract In some patients, therapy with botulinum toxin type A (BT‐A) becomes ineffective due to formation of antibodies (BT‐A‐AB). The time course of BT‐A‐AB titres after cessation of BT‐A therapy was quantitatively studied to determine whether and when they might drop. Thirteen patients (eight